Startups
At Clairity, we believe that everyone should know their risk of breast cancer and have access to life-saving screening technology. Clairity's mammography-based deep learning platform is revolutionizing the screening process by improving accuracy, eliminating bias, cultivating trust, reducing the cost of care and saving lives.
Overview
Location
United States, Texas, Austin
Employees
11-50
Founded date
2020
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 2, 2025 | Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health | CLAIRITY BREAST provides clinicians with a first-in-class, novel platform for identifying future risk of breast cancer A milestone in equitable healthcare, with potentially life-saving insights from a screening mammogram alone FDA grants De... |
| Clairity | “BETTER SCIENCE LEADS TO BETTER CARE. Clairity leverages the power of artificial intelligence to amplify the impact of healthcare providers, empower patients, and deliver on the promise of precision medicine. LEARN MORE “Too many patients ... | |
| Clairity | “What if you could predict the risk of breast cancer? CLAIRITY BREAST CLAIRITY BREAST is the first FDA-authorized AI platform that predicts a woman’s five-year future risk of developing breast cancer, using only her existing screening mammo... |
Reviews 0
FAQ about Clairity, Inc.
When was Clairity, Inc. founded?
Clairity, Inc. was founded in 2020.
What has the press written about Clairity, Inc.?
Parsers VC has collected 4 articles mentioning Clairity, Inc., among them “Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health” (Jun 2, 2025) and “Clairity”.
Is Clairity, Inc. still active?
Yes, Clairity, Inc. is active; its latest activity on Parsers VC dates from Nov 13, 2025.